Trial Profile
uPAR-PET/MR in Glioblastoma Multiforme
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2023
Price :
$35
*
At a glance
- Drugs Gallium-68 NOTA AE105 (Primary)
- Indications Glioblastoma
- Focus Diagnostic use
- Acronyms uPAR-PET/MR in glioma
- 29 Jun 2023 Results from the study, carried out at According to Curasight Media Release,Results from the study, carried out at Rigshospitalet in Copenhagen, will be presented at the World Molecular Imaging Congress (WMIC) in Prague, September 2023.
- 04 Apr 2017 Status changed from not yet recruiting to recruiting.
- 13 Oct 2016 New trial record